In october, HTL Biotechnology hosted the 2026 Regenerative Science Summit | PDRN/PN Edition in Chengdu, China. The event gathered over 130 participants from scientific research, regulatory affairs, product development and clinical practice, providing a platform for knowledge sharing and discussion on the evolving field of PDRN/PN.
Throughout the day, experts shared their insights through a series of presentations addressing key topics, including PDRN/PN market trends, scientific advances, evaluation methods, regulatory considerations and emerging applications.
The programme also featured a roundtable discussion exploring the future of PDRN/PN in China, encouraging exchanges between participants and offering fresh perspectives on the opportunities and challenges shaping this field.
HTL Biotechnology would like to warmly thank all speakers, the moderator and attendees for their valuable contributions and engagement throughout the summit.
Special thanks also go to 博迈思_BorMedicals, the event organising agency, and Medbelove, the official media partner, for their support in making this event possible.
Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.
On June 4th, as part of the 3rd edition of the National Biopharmaceutical Bioproduction Day (#JNBB2026) organized by France BioLead, HTL Biotechnology was pleased to open the doors of its Javené facility to students and teachers who came to learn about careers in bioproduction.
At HTL Biotechnology, a culture of safety is deeply ingrained in our daily operations and guides all of our industrial practices. It is part of a clear goal: striving for zero accidents by placing prevention at the heart of our actions.